Serious and rarer side effects can include muscle cramping, irregular heartbeat, shortness of breath, slurred speech, vision changes, chest pain and weakness on one side of the body
Moreover, based on the individual expression of TOP2, a suitable (or alternative) chemotherapy regimen may be chosen, however further studies are needed to explore this concept ( Current experimental studies on possible cardioprotective agents have mostly been conducted on animal (murine) model with promising results
These agents are investigational or research use in many settings and are not approved for general clinical use
Not for human consumption, veterinary use, or clinical administration
Plasma metabolomics and network pharmacology identified glutamate, glutamine, and arginine as biomarkers of depression under Shuganjieyu capsule treatment